Successful treatment of low-grade endometrial cancer in premenopausal women with an aromatase inhibitor after failure with oral or intrauterine progesterone
Introduction: Young women with endometrial intraepithelial hyperplasia or low-grade endometrial carcinoma are potential candidates for conservative fertility sparing therapy utilizing progesterone rather than hysterectomy. High-dose progesterone treatment is associated with 55-80% initial response b...
Saved in:
Main Authors: | Alli Straubhar (Author), Andrew P. Soisson (Author), Mark Dodson (Author), Elise Simons (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2017-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluating the role of aromatase inhibitors in the treatment of low-grade endometrial stromal sarcomas
by: Fionnuala Crowley, et al.
Published: (2022) -
Comparison of gonadotropin releasing hormone agonists (GNRHA) vs aromatase inhibitors on volume of uterine leiomyomas in premenopausal women
by: Uzma Hussain, et al.
Published: (2023) -
Effect of a hormone-releasing intrauterine system (Mirena®) on aromatase and Cox-2 expression in patients with adenomyosis submitted or not, to endometrial resection
by: Maia R, et al.
Published: (2012) -
The temporal reliability of serum estrogens, progesterone, gonadotropins, SHBG and urinary estrogen and progesterone metabolites in premenopausal women
by: Stanczyk Frank Z, et al.
Published: (2002) -
PREDICTION ENDOMETRIAL CANCER IN WOMEN WITH ENDOMETRIAL HYPERPLASTIC PROCESSES IN PREMENOPAUSAL
by: A. L. Unanyan, et al.
Published: (2016)